Products

What will AGI do for Apomorphine hydrochloride?

This classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula 2C17H17NO2.2ClH.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F39049Y068, chemically known as 6a.beta.-noraporphine-10,11-diol, 6-methyl-, hydrochloride but more generally known as apomorphine hydrochloride, which bears US NIH Compound Identifier 2215. European Medicines Agency schedules Apomorphine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12924MIG. Most nations, for tariff and trade purposes, schedule apomorphine hydrochloride under HS 29391900. As of Q4 2014, APOMORPHINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Apomorphine hydrochloride bears US NLM identifiers UMLS ID C0237406 and NCI Concept Code C47400. SMILES: CN1CCC2CCCC-3C2[C@H]1CC4C3C(C(CC4)O)O.CN1CCC2CCCC-3C2[C@H]1CC4C3C(C(CC4)O)O.O.CL.CL.

How AGI delivers it

Four ways AGI delivers for Apomorphine hydrochloride

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Apomorphine hydrochloride, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Apomorphine hydrochloride, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Apomorphine hydrochloride connects

measured by

  • Assay Puritymodel
  • Chromatographic Impurity Profilemodel
  • Optical Rotationmodel
  • Residual Solventmodel